Function and well-being in systemic sclerosis
Part of Skin clinical trials.
This trial looks at how systemic sclerosis affects daily function and mental well-being, including social and emotional factors. It may help patients understand their condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with systemic sclerosis
- You are between 18 and 65 years old
- You can read and understand written information
- You do not have a severe physical disability
- You do not have pulmonary hypertension
- You are not currently pregnant and do not have an active infection or severe neuropsychiatric condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how scleroderma affects physical performance and daily function in children and adults. It aims to understand the impact of the disease on movement and everyday activities.
This trial uses a simple 6-minute pegboard ring test to check how well your hands work. It aims to understand hand function in scleroderma and may help find new ways to track your health.
This study is testing a new scale to measure what it's like to live with hand problems caused by systemic sclerosis (scleroderma). By answering questions about your daily hand function, you can help doctors better understand your experience and improve care.
This study looks at how systemic sclerosis (a chronic autoimmune disease that can affect connective tissues) might relate to pelvic floor problems and sexual health issues in women. It compares women who have the condition with healthy women to find patterns that could lead to better care.
This study tests whether blocking a protein called TL1A can help reduce skin thickening and improve the immune system in people with systemic sclerosis (a condition where skin becomes hard and thick). Researchers will compare skin and blood samples from people with systemic sclerosis to healthy volunteers.
This trial tests whether special cells from umbilical cord (UC-MSC) can help treat systemic sclerosis—a disease that causes skin and organ hardening. If you have early systemic sclerosis that hasn't improved enough with standard treatments, this study may offer a new option.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.